TPQP is a quantitative surrogate for aspects of clinical
safety and efficacy that can be used to design and optimize
formulation and manufacturing process. It should include
quantitative targets for impurities and stability, release
profiles (dissolution) and other product specific performance
requirements。
CQAs are physical, chemical, biological or microbiological
properties or characteristics that need to be controlled
(directly or indirectly) or within an appropriate limit, range, or
distribution to ensure the desired product quality。
CMA are physical, chemical, biological or microbiological
properties or characteristics of materials including drug
substance, excipients, in-process materials and drug product,
that need to be controlled to ensure the desired product
quality。